Gene · 970
Papers4,349
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
401 to 420 of 4,349
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The nexus of natural killer cells and melanoma tumor microenvironment: crosstalk, chemotherapeutic potential, and innovative NK cell-based therapeutic strategies. | Cancer Cell Int | 2023 | 38057843 | PubTator, text mining | PubMed |
| [The guidelines for diagnosis and treatment of relapse /refractory acute myelogenous leukemia in China (2023)]. | Zhonghua Xue Ye Xue Za Zhi | 2023 | 38049313 | PubTator, text mining | PubMed |
| TRAIL-dependent apoptosis of peritoneal mesothelial cells by NK cells promotes ovarian cancer invasion. | iScience | 2023 | 38047087 | PubTator, text mining | PubMed |
| Identification and validation of 5-methylcytosine-associated genes in diffuse large B-cell lymphoma. | Heliyon | 2023 | 38045198 | PubTator, text mining | PubMed |
| Past, present and future therapeutic approaches in nodal peripheral T-cell lymphomas. | Haematologica | 2023 | 38037799 | PubTator, text mining | PubMed |
| RNA-sequencing based first choice of treatment and determination of risk in multiple myeloma. | Front Immunol | 2023 | 38035078 | PubTator, text mining | PubMed |
| Emerging roles for tumor stroma in antigen presentation and anti-cancer immunity. | Biochem Soc Trans | 2023 | 38031753 | PubTator, text mining | PubMed |
| Delayed vaccine-induced CD8+ T cell expansion by topoisomerase I inhibition mediates enhanced CD70-dependent tumor eradication. | J Immunother Cancer | 2023 | 38030302 | PubTator, text mining | PubMed |
| Inv(3) Acute Myeloid Leukemia in a Young Adult and Review of the Literature. | Case Rep Oncol Med | 2023 | 38026762 | PubTator, text mining | PubMed |
| Fusing WGCNA and Machine Learning for Immune-Related Gene Prognostic Index in Lung Adenocarcinoma: Precision Prognosis, Tumor Microenvironment Profiling, and Biomarker Discovery. | J Inflamm Res | 2023 | 38026246 | PubTator, text mining | PubMed |
| Large-scale analysis of cell-cell communication reveals angiogenin-dependent tumor progression in clear cell renal cell carcinoma. | iScience | 2023 | 38025776 | PubTator, text mining | PubMed |
| Adoptive NK Cell Therapy - a Beacon of Hope in Multiple Myeloma Treatment. | Front Oncol | 2023 | 38023191 | PubTator, text mining | PubMed |
| Editorial: TNFRSF agonists: mode of action and therapeutic opportunities. | Front Immunol | 2023 | 38022660 | PubTator, text mining | PubMed |
| Mimicking the brain: Epstein-Barr virus and foreign agents as drivers of neuroimmune attack in multiple sclerosis. | Front Immunol | 2023 | 38022632 | PubTator, text mining | PubMed |
| Ligand-based targeting of c-kit using engineered γδ T cells as a strategy for treating acute myeloid leukemia. | Front Immunol | 2023 | 38022523 | PubTator, text mining | PubMed |
| Too much of a good thing: a review of primary immune regulatory disorders. | Front Immunol | 2023 | 38022498 | PubTator, text mining | PubMed |
| Development of a diagnostic and risk prediction model for Alzheimer's disease through integration of single-cell and bulk transcriptomic analysis of glutamine metabolism. | Front Aging Neurosci | 2023 | 38020758 | PubTator, text mining | PubMed |
| Current trends of clinical trials involving CRISPR/Cas systems. | Front Med (Lausanne) | 2023 | 38020120 | PubTator, text mining | PubMed |
| Identifying prognostic characteristics of m6A-related glycolysis gene and predicting the immune infiltration landscape in bladder cancer. | Cancer Cell Int | 2023 | 38017469 | PubTator, text mining | PubMed |
| Antigenic targets in clear cell renal cell carcinoma. | Kidney Cancer | 2023 | 38014393 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/970/papers?page=21